Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Lymphoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neoplasms 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Stomach Neoplasms 1 Sarcoma 1 Recurrence 1 Prostatic Neoplasms 1 Neuroblastoma 1 Neoplasm Metastasis 1 Glioblastoma 1 Drug-Related Side Effects and Adverse Reactions 1 Depression 1 Central Nervous System Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Anxiety Disorders 1 All Solid Tumors 1

Interventions

Pharmaceutical Preparations 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × All Solid Tumors × Pharmaceutical Preparations × Clear all

NCT01711398 2015-02-12

IP N02

Elro Pharma

Phase 1/2 Completed

Other solid neoplasm

All Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡